tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
US Market
ARQT
Arcutis Biotherapeutics
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Arcutis Biotherapeutics (ARQT) Stock News & Sentiment

Compare
792 Followers
Strong Recovery and Growth in Zoryve Prescriptions Boosts Buy Rating for Arcutis Biotherapeutics
Premium
Ratings
Strong Recovery and Growth in Zoryve Prescriptions Boosts Buy Rating for Arcutis Biotherapeutics
17d ago
ARQT
Arcutis Biotherapeutics Shines in Earnings Call
Premium
Company Announcements
Arcutis Biotherapeutics Shines in Earnings Call
28d ago
ARQT
Strong Buy Rating for Arcutis Biotherapeutics Driven by Zoryve’s Growth and Market Expansion
Premium
Ratings
Strong Buy Rating for Arcutis Biotherapeutics Driven by Zoryve’s Growth and Market Expansion
29d ago
ARQT
Arcutis Biotherapeutics: Strong Buy Rating Backed by Surpassing Sales and Promising Pipeline
Premium
Ratings
Arcutis Biotherapeutics: Strong Buy Rating Backed by Surpassing Sales and Promising Pipeline
30d ago
ARQT
Strong Sales Growth and Financial Stability Drive Buy Rating for Arcutis Biotherapeutics
Premium
Ratings
Strong Sales Growth and Financial Stability Drive Buy Rating for Arcutis Biotherapeutics
30d ago
ARQT
Arcutis Biotherapeutics Reports Strong 2024 Revenue Growth
Premium
Company Announcements
Arcutis Biotherapeutics Reports Strong 2024 Revenue Growth
30d ago
ARQT
Strong Market Position and Growth Potential for Arcutis Biotherapeutics Driven by Zoryve’s Success and Strategic Initiatives
Premium
Ratings
Strong Market Position and Growth Potential for Arcutis Biotherapeutics Driven by Zoryve’s Success and Strategic Initiatives
30d ago
ARQT
More ARQT News >

ARQT News on the Web

Arcutis Biotherapeutics Inc (ARQT) to Participate in 24th Annual Needham Virtual Healthcare ...
GuruFocus News
Bullish
Rebound Or Fakeout? The 200-Day MA Holds The Key To The Next Big Move
TalkMarkets
Neutral
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Arcutis Biotherapeutics (ARQT)
TipRanks News
Neutral
Market Today: Alphabet Eyes $30B Wiz Deal Amid Intel's Strategic Shifts
GuruFocus News
Neutral
Arcutis Canada: Health Canada Approves ZORYVE Cream 0.15% - Quick Facts
rttnews
Neutral
Has Arcutis Biotherapeutics (ARQT) Outpaced Other Medical Stocks This Year?
Zacks
Neutral
Arcutis to Highlight Data from Phase 3 Trials for Scalp and Body Psoriasis and Atopic Dermatitis at the 83rd American Academy of Dermatology Meeting
Yahoo Finance
Neutral
Arcutis Biotherapeutics, Inc. Just Overtook the 50-Day Moving Average
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
ARQT
Sector Average
Media Buzz
This Week3 articles
Weekly Average3 articles
News Sentiment
This Week100%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ARQT’s Media Buzz Sentiment?
3 articles about ARQT were published this week. In an average week, 3 articles are published.
    What is ARQT’s weekly average amount of articles?
    In an average week, 3 articles about ARQT are published.
      What is ARQT’s News Sentiment?
      100% of articles about ARQT were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        ALCAlcon
        SLNOSoleno Therapeutics
        BHCBausch Health Companies
        DYAIDyadic International
        ASMBAssembly Biosciences
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing